Acorda Therapeutics Inc
General ticker "ACOR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.0M
Acorda Therapeutics Inc does not follow the US Stock Market performance with the rate: -11.6%.
Estimated limits based on current volatility of 12.3%: low 0.86$, high 1.10$
Factors to consider:
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term predictions were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 predicted range: [4.73$, 15.71$]
- 2023-12-31 to 2024-12-30 predicted range: [3.69$, 12.45$]
Short-term ACOR quotes
Long-term ACOR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $130.23MM | $131.16MM | $117.63MM |
| Operating Expenses | $209.26MM | $166.50MM | $140.90MM |
| Operating Income | $-79.04MM | $-35.34MM | $-23.26MM |
| Non-Operating Income | $-30.04MM | $0.09MM | $-272.76MM |
| Interest Expense | $30.04MM | $28.29MM | $31.53MM |
| R&D Expense | $10.42MM | $5.80MM | $5.15MM |
| Income(Loss) | $-109.07MM | $-35.25MM | $-296.02MM |
| Taxes | $-5.12MM | $30.67MM | $-43.17MM |
| Profit(Loss) | $-103.95MM | $-65.92MM | $-252.85MM |
| Stockholders Equity | $151.14MM | $93.62MM | $-157.96MM |
| Assets | $455.47MM | $395.60MM | $117.75MM |
| Operating Cash Flow | $-41.35MM | $-20.92MM | $-13.98MM |
| Investing Cash Flow | $73.78MM | $-0.14MM | $-0.26MM |
| Financing Cash Flow | $-69.66MM | $0.51MM | $0.00MM |
| Earnings Per Share* | $-195.75 | $-66.90 | $-203.59 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.